Gland Pharma Limited (GLAND.BO) Stock Analysis & Winston Score

Gland Pharma is an Indian pharmaceutical company that makes injectable medicines, including pre-filled syringes, vials, and ampoules. It produces both generic and branded injectable drugs used in hospitals and clinics around the world. The company is one of the largest injectable-focused drugmakers globally and is majority-owned by China's Fosun Pharma. Gland Pharma earns revenue by manufacturing and selling finished injectable products as well as through contract manufacturing for other pharma companies. It is headquartered in Hyderabad, India, and exports to markets including the United States, Europe, Canada, and Australia. Its focus solely on injectables gives it deep manufacturing expertise and regulatory approvals across multiple countries, which are hard for competitors to replicate quickly. Key growth drivers include expanding its product pipeline for the US generics market and adding biologics capabilities, though pricing pressure in the generic drug space and regulatory risks remain ongoing challenges.